| Primary |
| Product Used For Unknown Indication |
19.5% |
| Drug Use For Unknown Indication |
14.0% |
| Convulsion |
12.8% |
| Epilepsy |
11.6% |
| Essential Tremor |
9.8% |
| Tremor |
7.9% |
| Maternal Exposure During Pregnancy |
4.9% |
| Partial Seizures |
2.4% |
| Complex Partial Seizures |
1.8% |
| Drug Exposure Via Breast Milk |
1.8% |
| Foetal Exposure During Pregnancy |
1.8% |
| Grand Mal Convulsion |
1.8% |
| Bipolar Disorder |
1.2% |
| Bronchitis |
1.2% |
| Dyspepsia |
1.2% |
| Familial Tremor |
1.2% |
| Head Titubation |
1.2% |
| Hormone Replacement Therapy |
1.2% |
| Myoclonic Epilepsy |
1.2% |
| Polymyalgia Rheumatica |
1.2% |
|
| Somnolence |
10.6% |
| Therapeutic Response Unexpected With Drug Substitution |
10.6% |
| Product Substitution Issue |
8.5% |
| Toxicity To Various Agents |
6.4% |
| Tremor |
6.4% |
| Death |
4.3% |
| Drug Ineffective |
4.3% |
| Grand Mal Convulsion |
4.3% |
| Loss Of Consciousness |
4.3% |
| Multiple Drug Overdose |
4.3% |
| Pharmaceutical Product Complaint |
4.3% |
| Poisoning |
4.3% |
| Rash |
4.3% |
| Respiratory Arrest |
4.3% |
| Speech Disorder |
4.3% |
| Vomiting |
4.3% |
| Weight Increased |
4.3% |
| Adverse Event |
2.1% |
| Alopecia |
2.1% |
| Atrial Flutter |
2.1% |
|
| Secondary |
| Product Used For Unknown Indication |
24.6% |
| Drug Abuse |
18.0% |
| Epilepsy |
13.4% |
| Convulsion |
8.4% |
| Drug Use For Unknown Indication |
8.2% |
| Parkinson's Disease |
5.5% |
| Dyspepsia |
3.2% |
| Tremor |
2.1% |
| Foetal Exposure During Pregnancy |
2.1% |
| Depression |
1.8% |
| Diabetes Mellitus |
1.7% |
| Hysterectomy |
1.4% |
| Migraine |
1.4% |
| Grand Mal Convulsion |
1.3% |
| Seasonal Affective Disorder |
1.3% |
| Upper Respiratory Tract Inflammation |
1.3% |
| Fungal Infection |
1.1% |
| Asthma |
1.0% |
| Blood Testosterone Abnormal |
1.0% |
| Bronchitis |
1.0% |
|
| Tremor |
9.2% |
| Completed Suicide |
8.5% |
| Parkinson's Disease |
8.5% |
| Toxicity To Various Agents |
8.5% |
| Swelling Face |
7.7% |
| Drug Interaction |
6.9% |
| Weight Increased |
6.9% |
| Multiple Drug Overdose |
5.4% |
| Convulsion |
4.6% |
| Somnolence |
4.6% |
| Maternal Exposure Timing Unspecified |
3.8% |
| Stevens-johnson Syndrome |
3.8% |
| Balance Disorder |
3.1% |
| Foetal Exposure During Pregnancy |
3.1% |
| Osteoporosis |
3.1% |
| Pruritus |
3.1% |
| Cardio-respiratory Arrest |
2.3% |
| Drug Ineffective |
2.3% |
| Drug Toxicity |
2.3% |
| Hypertension |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
21.8% |
| Drug Use For Unknown Indication |
12.0% |
| Epilepsy |
7.5% |
| Convulsion |
5.7% |
| Tremor |
5.7% |
| Depression |
5.5% |
| Hypertension |
5.2% |
| Pain |
4.4% |
| Multiple Sclerosis |
4.3% |
| Osteoporosis |
3.7% |
| Rheumatoid Arthritis |
3.6% |
| Parkinson's Disease |
3.1% |
| Chronic Obstructive Pulmonary Disease |
2.8% |
| Diabetes Mellitus |
2.6% |
| Asthma |
2.4% |
| Essential Tremor |
2.3% |
| Blood Cholesterol Increased |
2.0% |
| Gastrooesophageal Reflux Disease |
1.9% |
| Bipolar Disorder |
1.8% |
| Anxiety |
1.7% |
|
| Weight Increased |
12.1% |
| Tremor |
11.7% |
| Weight Decreased |
8.9% |
| Urinary Tract Infection |
6.4% |
| Vomiting |
6.2% |
| Drug Ineffective |
5.1% |
| Somnolence |
4.9% |
| Convulsion |
4.7% |
| Pain |
4.2% |
| Death |
4.0% |
| Suicidal Ideation |
3.8% |
| Rash |
3.4% |
| Syncope |
3.4% |
| Nausea |
3.2% |
| Off Label Use |
3.2% |
| Pneumonia |
3.2% |
| Diarrhoea |
3.0% |
| Pyrexia |
3.0% |
| Rash Generalised |
3.0% |
| Inguinal Hernia |
2.8% |
|
| Interacting |
| Epilepsy |
64.9% |
| Upper Respiratory Tract Inflammation |
10.4% |
| Drug Use For Unknown Indication |
9.1% |
| Reflux Oesophagitis |
5.2% |
| Convulsion |
2.6% |
| Osteopenia |
2.6% |
| Product Used For Unknown Indication |
2.6% |
| Gallbladder Operation |
1.3% |
| Respiratory Disorder |
1.3% |
|
| Drug Interaction |
27.3% |
| Overdose |
18.2% |
| Convulsion |
13.6% |
| Hallucination |
13.6% |
| Altered State Of Consciousness |
4.5% |
| Anticonvulsant Drug Level Above Therapeutic |
4.5% |
| Anticonvulsant Drug Level Increased |
4.5% |
| Hyperammonaemia |
4.5% |
| Injection Site Pain |
4.5% |
| Weight Decreased |
4.5% |
|
